RT Journal Article
T1 Functional Outcomes in Patients with Hemorrhagic Stroke during SARS-CoV-2 Pandemic. A Descriptive Study
A1 Pego Pérez, Emilio Rubén
A1 Bermello López, María Lourdes
A1 Rodríguez Pérez, Isidoro
A1 Marín Arnés, María del Rosario
A1 Gómez Fernández, Eva
K1 Acute haemorragic stroke
K1 IADL
K1 Autonomy
K1 Barthel index
K1 Outcomes
K1 Quality of life
K1 SARS-CoV-2
AB Background: Stroke is the second leading cause of death worldwide and one of the leading causes of disability in adults. About 85% of them will be ischemic, and the other 15%, hemorrhagic stroke. Evidence suggested that COVID-19 patients may experience increased rates of thromboembolism and the risk of a hemorrhagic stroke.Aim: to determine the functional outcomes in patients with hemorrhagic stroke during the SARS-CoV-2 pandemic.Methods: a descriptive and retrospective study that included a sample of 92 patients with acute hemorrhagic stroke. The functional outcomes were measured with Barthel Index.Results: The distribution in the moderate and severe degrees has been higher for the year 2019, in the independent and minimal help required degrees it has been higher in the year 2020. No significant correlation was found between age and the categorized Barthel Index, not between the year and the categorized Barthel Index.Conclusion: No relationship is seen between the SARS-CoV-2 pandemic and worsening of functionality. The structural changes during the pandemic and the reduction in personnel have not affected the diagnosis and involvement of ischemic stroke. The effort of the staff, to maintain adequate care, has been decisive in the functional results of the patients.
PB Juniper Publishers
SN 2476-0501
YR 2022
FD 2022-08-26
LK https://hdl.handle.net/10347/39720
UL https://hdl.handle.net/10347/39720
LA eng
NO Pego Pérez, E.R., Bermello López, M.L., Rodríguez Pérez, I., Marín Arnés, M.R. & Gómez Fernández, E. (2022). Functional Outcomes in Patients with Hemorrhagic Stroke during SARS-CoV-2 Pandemic. A Descriptive Study. Open Access Journal of Neurology & Neurosurgery, 17(3). doi: 10.19080/OAJNN.2022.17.555963
DS Minerva
RD 29 abr 2026